Navigation Links
hKvLQT1/hminK-CHO K1 Recombinant Cell Line from Upstate

ProductshKvLQT1/hminK-CHO K1 Recombinant Cell Line from Upstate
Company Upstate
Item hKvLQT1/hminK-CHO K1 Recombinant Cell Line
Price 
Description PrecisION Ion Channel Cell Lines
High Quality, Functionally-Validated, Ion Channel Cell Lines

Ion channels are well known for having a critical role in nerve and muscle function and consequently have a key function in pain, CNS and the heart. Drugs that modulate ion channels have been investigated in therapeutic areas, such as neuropathic pain, cardiac arrhythmia, hypertension, local anaesthesia, stroke, Parkinson's, obesity, epilepsy, diabetes and depression.

Historically, ion channels have been under exploited as drug targets primarily due to the lack of functional high throughput screening technologies. Over recent years, there has been considerable progress in this important area. However, now there is a requirement for high quality research tools that will allow the full benefit of the new screening technologies to be realised. Upstate has built a portfolio of ion channel cell lines to meet these new and evolving needs in the drug discovery industry.

Our ion channel cell lines are available off of the shelf. These cell lines are fully validated using electrophysiology, stable (>25 passage) and licensed for drug discovery research. The objective is to provide the pharmaceutical industry with a range of ion channel cell lines to support drug discovery, lead optimisation and safety pharmacology functions.
Info UpstateUpstate
28820 Single Oak Drive
Temecula, CA 92590
Customer Service: 800-437-7500 or 951-676-8080
Tech Support: 800 548-7853
Fax Number: 800-437-7502 or 951-676-9209
Web Site: http://www.upstate.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Recombinant Expression of Peptides and Proteins: from rPeptide, LLC
2. Recombinant RNasin® Ribonuclease Inhibitor from Promega
3. GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.
4. RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen
5. hKv4.2/hKChIP2-CHO K1 Recombinant Cell Line from Upstate
6. hERG-CHO K1 Recombinant Cell Line from Upstate
7. hERG-CHO K1 Recombinant Cell Line from Upstate
8. hHCN4-CHO K1 Recombinant Cell Line from Upstate
9. hKv1.5-CHO K1 Recombinant Cell Line from Upstate
10. hNav1.6-HEK293 Recombinant Cell Line from Upstate
11. Smac/DIABLO, Human, Recombinant, E. coli from Calbiochem
MAb to Mouse MHC Class I H-2Kd...
... contains a unique β-agarose digesting enzyme developed ... intact DNA and RNA from low melting ... TAE, TBE, MOPS, or phosphate buffers. The ... TAE, TBE, MOPS, and phosphate electrophoresis buffers ...
... a recombinant preparation of the catalytic subunit ... expressed and isolated from the yeast Pichia ... preparation (2). It recognizes the sequence Asp-Asp-Asp-Asp-Lys ... lysine residue. The enzyme can be used ...
Topoisomerase I...
Biology Products:
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):
(Date:6/23/2016)...  Blueprint Bio, a company dedicated to identifying, protecting ... has closed its Series A funding round, according to ... "We have received a commitment from Forentis Fund that ... meet our current goals," stated Matthew Nunez . ... complete validation on the current projects in our pipeline, ...
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
(Date:6/23/2016)... ... 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), a ... webinar on Performing Quality Investigations: Getting to Root Cause. This ... charge. , Incomplete investigations are still a major concern to the Regulatory Authorities ...
(Date:6/23/2016)... FRANCISCO , June 22, 2016  Amgen (NASDAQ: ... sponsorship of the QB3@953 life sciences incubator ... human health. The shared laboratory space at QB3@953 was ... overcome a key obstacle for many early stage organizations ... part of the sponsorship, Amgen launched two "Amgen Golden ...
Breaking Biology Technology: